Cargando…

Impact of primary colorectal Cancer location on the KRAS status and its prognostic value

BACKGROUND: Colorectal cancer (CRC) originating from the right-sided or left-sided colon is distinct clinicopathological entity. The KRAS status and its prognostic value in CRC remain controversial. This study aimed to investigate the association of KRAS status with clinicopathological features and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Ming-zhi, Li, Ji-lin, Cai, Zheng-min, Li, Ke-zhi, Hu, Bang-li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437985/ https://www.ncbi.nlm.nih.gov/pubmed/30917791 http://dx.doi.org/10.1186/s12876-019-0965-5

Ejemplares similares

Prognostic value of peripheral blood natural killer cells in colorectal cancer
por: Tang, Yan-ping, et al.
Publicado: (2020)

Prognostic Value of Autophagy, Microsatellite Instability, and KRAS Mutations in Colorectal Cancer
por: Wang, Yuanyuan, et al.
Publicado: (2021)

KRAS Status is Associated with Metabolic Parameters in Metastatic Colorectal Cancer According to Primary Tumour Location
por: Tabuso, M., et al.
Publicado: (2020)

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
por: Koulouridi, Asimina, et al.
Publicado: (2022)

Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?
por: Liu, Fangqi, et al.
Publicado: (2017)

Clinical Significance and Prognostic Value of the Maximum Standardized Uptake Value of (18)F-Flurodeoxyglucose Positron Emission Tomography–Computed Tomography in Colorectal Cancer
por: Yin, Yi-xin, et al.
Publicado: (2021)

Prognostic Value of the Tumor Size in Resectable Colorectal Cancer with Different Primary Locations: A Retrospective Study with the Propensity Score Matching
por: Li, Xiao, et al.
Publicado: (2019)

KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients
por: Sun, De-cong, et al.
Publicado: (2017)

Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
por: Ucar, Gokhan, et al.
Publicado: (2020)

Prognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients
por: Guo, Tianan, et al.
Publicado: (2021)

The impact of primary tumor location on efficacy of cetuximab in metastatic colorectal cancer patients with different Kras status: a systematic review and meta-analysis
por: Cao, De-Dong, et al.
Publicado: (2017)

Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis
por: Dai, Dongjun, et al.
Publicado: (2020)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
por: Kim, Mi-Jung, et al.
Publicado: (2012)

Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
por: Popovici, Vlad, et al.
Publicado: (2013)

Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations
por: Li, Wenbin, et al.
Publicado: (2015)

Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
por: Guo, Fang, et al.
Publicado: (2018)

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
por: Won, Daeyoun David, et al.
Publicado: (2017)

Histology and its prognostic effect on KRAS-mutated colorectal carcinomas in Korea
por: Lee, Hye Seung, et al.
Publicado: (2020)

The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2013)

The Prognostic Value of (18)F-FDG PET/CT and KRAS Mutation in Colorectal Cancers
por: Arslan, Esra, et al.
Publicado: (2020)

Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma
por: Díez-Alonso, Manuel, et al.
Publicado: (2021)

KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China
por: Lian, Shen-Yi, et al.
Publicado: (2023)

Clinical Significance and Prognostic Value of miR-28-5p in Colon Cancer
por: Li, Ji-lin, et al.
Publicado: (2020)

Relationships among KRAS mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer
por: Wan, Xiang-Bin, et al.
Publicado: (2019)

Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation
por: Pang, Xue-Lian, et al.
Publicado: (2017)

Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
por: Lavacchi, Daniele, et al.
Publicado: (2022)

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
por: Eilertsen, Ina A., et al.
Publicado: (2018)

Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
por: Arrington, Amanda K., et al.
Publicado: (2012)

Evaluation of the Prognostic Value of Low-Frequency KRAS Mutation Detection in Circulating Tumor DNA of Patients with Metastatic Colorectal Cancer
por: Lin, Chien-Yu, et al.
Publicado: (2023)

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?
por: Fang, Yujing, et al.
Publicado: (2023)

Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
por: Dai, Manxiong, et al.
Publicado: (2022)

The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
por: Xie, Wenli, et al.
Publicado: (2019)

Periostin Expression and Its Prognostic Value for Colorectal Cancer
por: Li, Zewu, et al.
Publicado: (2015)

Systematic Analysis of the Clinical Significance of Hyaluronan-Mediated Motility Receptor in Colorectal Cancer
por: Tang, Yan-ping, et al.
Publicado: (2021)

The predictive value of KRAS and NRAS mutations in metastatic colorectal cancer
por: Eshraghi, Abbas, et al.
Publicado: (2020)

Prognostic value of gender and primary tumor location in metastatic colon cancer
por: Grassadonia, Antonino, et al.
Publicado: (2023)

The value of haematological parameters and serum tumour markers for predicting KRAS mutations in 784 Chinese colorectal cancer patients: a retrospective analysis
por: Cao, Yinghao, et al.
Publicado: (2020)

Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
por: Palomba, Grazia, et al.
Publicado: (2016)

The role of kras mutations and MSI status in diagnosis of colorectal cancer
por: Shemirani, Atena Irani, et al.
Publicado: (2011)

The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients
por: Cai, Dongjing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_79b0g9ikdopna0buin08vdpdvi